Manatt’s Ian Spatz, a senior advisor for Manatt Health, spoke to Axios about the Trump administration’s new rules requiring drugmakers to include prices in TV ads.
Nine Manatt practices and 24 lawyers were named to Chambers USA’s 2019 list of leading lawyers for business in the United States. Manatt Health leader William Bernstein received a Band 1 ranking for Healthcare—New York for the ninth consecutive year, and Manatt Entertainment ...
Twelve Manatt attorneys have been named to the 2018 Capital Pro Bono Honor Roll, released by the District of Columbia Courts.
Joel Ario, managing director of Manatt Health, spoke with the Los Angeles Times on short-term health plans and how they have been impacted by the Trump administration’s relaxation of Obama-era healthcare regulations.
Manatt’s Patricia Boozang, senior managing director at Manatt Health, spoke to FierceHealthcare about a recent ruling by a District of Columbia court that blocks Medicaid work requirements in Kentucky and Arkansas.
Manatt’s Joel Ario, a managing director with Manatt Health, spoke to The Washington Post about the Trump administration’s approach to the Affordable Care Act and its potential impact on insurance marketplaces.
Manatt’s Joel Ario, managing director of Manatt Health, spoke to InsideHealthPolicy about New Jersey’s recent move from a federal to a state-based healthcare exchange program, and about how other states could soon follow suit.
Manatt’s Fatema Zanzi, a partner with Manatt Health, spoke to FierceHealthcare about a recently released Manatt Health study on inpatient psychiatric facilities and their compliance with the Centers for Medicare & Medicaid Services.
Manatt Health’s recent report, “Assessing the Regulatory Burden on Inpatient Psychiatric Facilities,” on inpatient psychiatric facility regulations was detailed in a new article in Modern Healthcare.The study found that inpatient psychiatric facilities across the country face over ...
Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke to CNN about partisan disagreements in Congress regarding drug prices.